PEBP1 and central nervous system cancer: Maresch et al, in a recent publication using 159 gliomas, found that RKIP is present in 82% (22/27) of low-grade astrocytomas and only in ∼53% (67/126)of high grade gliomas, and the difference was statistically significant [28].